首页> 外国专利> MEDICAMENT COMPOSITION FOR PREVENTION AND TREATMENT OF ANALGESIC TOLERANCE TO MORPHINE COMPRISING BERBERINE AS EFFECTIVE COMPONENT WHICH CONTRIBUTES TO MAINTAIN INITIAL PAIN-RELIEVING ACTIVITY OF MORPHINE DURING REPEATED ADMINISTRATION OF MORPHINE

MEDICAMENT COMPOSITION FOR PREVENTION AND TREATMENT OF ANALGESIC TOLERANCE TO MORPHINE COMPRISING BERBERINE AS EFFECTIVE COMPONENT WHICH CONTRIBUTES TO MAINTAIN INITIAL PAIN-RELIEVING ACTIVITY OF MORPHINE DURING REPEATED ADMINISTRATION OF MORPHINE

机译:用于预防和治疗含有小BER碱的吗啡的镇痛药的药物组合物,有效成分在重复服用吗啡期间维持吗啡的初始止痛活性

摘要

PURPOSE: A medicament composition for prevention and treatment of analgesic tolerance to morphine comprising berberine as an effective component is provided, which medicament composition contributes to maintain initial pain-relieving activity of morphine during the repeated administration period of morphine. CONSTITUTION: The medicament composition for prevention and treatment of analgesic tolerance to morphine comprises berberine as an effective component and pharmaceutically acceptable carriers, wherein the berberine is 7, 8, 13, 13a-tetrahydro- 9,10-dimethoxy-2,3-(methylenedioxy)berberium; the berberine is extracted from the root of Coptis japonica or cortex of Phellodendron amurense; LD50 of berberine is 90 mg/kg in rat; and the medicament composition is administered orally or through an injection.
机译:目的:提供一种用于预防和治疗对吗啡的镇痛耐受性的药物组合物,其包含小ber碱作为有效成分,该药物组合物有助于在吗啡重复给药期间维持最初的吗啡止痛活性。组成:用于预防和治疗对吗啡的镇痛耐受性的药物组合物,包含小ber碱作为有效成分和药学上可接受的载体,其中小ber碱为7、8、13、13a-四氢-9,10-二甲氧基-2,3-(亚甲基二氧基)ber;小碱是从黄连或黄柏皮的根中提取的。小rat碱的LD50为90 mg / kg。所述药物组合物通过口服或注射给药。

著录项

  • 公开/公告号KR20050022713A

    专利类型

  • 公开/公告日2005-03-08

    原文格式PDF

  • 申请/专利权人 SUNGKYUNKWAN UNIVERSITY;

    申请/专利号KR20030060353

  • 发明设计人 JANG CHOON GON;

    申请日2003-08-29

  • 分类号A61K31/4375;

  • 国家 KR

  • 入库时间 2022-08-21 22:05:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号